П. Тодоров, Б. Нягулов, К. Пенчиков, В. Милачков, П. Бойчев. История Тутракана. Том ІІ (1878.1944). Силистра, Изд. .Ковачев., 2010. 668 с. / P. Todorov, B. Nyagulov, K. Penchikov, V. Milachkov. History of Trutrakan. Vol. 2 (1878 – 1944)

Autor: Lechev, Veliko

Publikováno v: Bulgarian Historical Review / Revue Bulgare d'Histoire / Bulgarian Historical Review. (1-2):219-225

Externí odkaz: https://www.ceeol.com/search/article-detail?id=146622

A randomized, double-blind study of zinpentraxin alfa in patients with myelofibrosis who were previously treated with or ineligible for ruxolitinib: stage 2 of a phase II trial.

Autor: Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX., Talpaz M; Michigan Medicine - The University of Michigan, Ann Arbor, MI., Wadleigh M; Dana-Farber Cancer Institute, Boston, MA., Isidori A; Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy., Te Boekhorst P; Erasmus Medical Center, Rotterdam, the Netherlands., Savona MR; Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Bose P; The University of Texas MD Anderson Cancer Center, Houston, TX., Pozdnyakova O; Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Mesa R; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC., El-Galaly TC; Department of Haematology, Aalborg University Hospital, Aalborg, Denmark., O'Sullivan J; Guy's and St Thomas' NHS Foundation Trust, London., Gamel K; F. Hoffmann-La Roche, Ltd., Basel., Higgins B; Genentech Inc, South San Francisco, CA., Katakam S; F. Hoffmann-La Roche, Ltd., Basel., Todorov B; F. Hoffmann-La Roche, Ltd., Basel., Trunzer K; F. Hoffmann-La Roche, Ltd., Basel., Harrison CN; Guy's and St Thomas' NHS Foundation Trust, London. claire.harrison@gstt.nhs.uk.

Publikováno v: Haematologica [Haematologica] 2024 Jun 01; Vol. 109 (6), pp. 1977-1983. Date of Electronic Publication: 2024 Jun 01.

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.

Autor: Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. sverstovsek@kartosthera.com., Foltz L; St Paul's Hospital, University of British Columbia, Vancouver., Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto., Hasserjian R; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Manshouri T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX., Pozdnyakova O; Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Ritchie E; Weill Cornell Medicine, New York, NY., Veletic I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Gamel K; F. Hoffmann-La Roche, Ltd., Basel., Hamidi H; Genentech Inc, South San Francisco, CA., Han L; Genentech Inc, South San Francisco, CA., Higgins B; Genentech Inc, South San Francisco, CA., Trunzer K; F. Hoffmann-La Roche, Ltd., Basel., Uguen M; F. Hoffmann-La Roche, Ltd., Basel., Wang D; F. Hoffmann-La Roche, Ltd., Basel., El-Galaly TC; F. Hoffmann-La Roche, Ltd., Basel, Switzerland; Current affiliation: Department of Hematology, Aalborg University Hospital, Aalborg., Todorov B; F. Hoffmann-La Roche, Ltd., Basel., Gotlib J; Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA.

Publikováno v: Haematologica [Haematologica] 2023 Oct 01; Vol. 108 (10), pp. 2730-2742. Date of Electronic Publication: 2023 Oct 01.

An approach to develop personalized radiopharmaceuticals by modifying 2-[18F]fluoro-2-deoxy-D-glucose (2-[18F]FDG).

Autor: Simeonova G; Clinic Nuclear Medicine, UMHAT 'St. Marina', Medical University, Varna, Bulgaria. gerimm@abv.bg.; Department of Analytical Chemistry, Faculty of Chemistry and Pharmacy, Sofia University, Bulgaria. gerimm@abv.bg., Todorov B; Department of Analytical Chemistry, Faculty of Chemistry and Pharmacy, Sofia University, Bulgaria.

Publikováno v: Nuclear medicine review. Central & Eastern Europe [Nucl Med Rev Cent East Eur] 2023; Vol. 26 (0), pp. 109-115.

Fractionation of ¹³⁷Cs and ⁶⁰Co in soils by sequential extractions.

Autor: Todorov, B.¹, Pekov, G.¹, Djingova, R.¹ RDjingova@chem.uni-sofia.bg

Publikováno v: Journal of Radioanalytical & Nuclear Chemistry. Oct2008, Vol. 278 Issue 1, p9-15. 7p. 2 Charts, 4 Graphs.